Avidity Partners Management LP - Significant Ownership

Signature - Title
By: Avidity Partners Management (GP) LLC, its general partner, By: /s/ Michael Gregory - Michael Gregory / Managing Member
Location
Dallas, TX
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Avidity Partners Management LP.

Email me when Avidity Partners Management LP files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Avidity Partners Management LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
CNTX Context Therapeutics Inc. Common Stock, par value $0.001 per share 9.9% $8.91M $72.1K 9.2M +0.82% Avidity Partners Management LP Sep 30, 2025
SCYX Scynexis, Inc. Common Stock, par value $0.001 per share 9.9% $3.48M $235K 4.52M +7.24% Avidity Private Master Fund I LP Sep 30, 2025
SYRS Syros Pharmaceuticals, Inc. Common Stock, $0.001 par value 7.6% $61.4K 2.05M Avidity Partners Management LP Dec 31, 2024
KZR Kezar Life Sciences, Inc. Common Stock, par value $0.001 per share 6.9% $397K 503K Avidity Partners Management LP Dec 31, 2024
DNTH Dianthus Therapeutics, Inc. Common Stock, $0.001 par value 4.9% $71M -$43M 2.1M -37.7% Avidity Partners Management LP Nov 17, 2025
IMUX Immunic, Inc. Common Stock, $0.0001 par value 4.8% $4.14M -$808K 4.7M -16.3% Avidity Partners Management LP Sep 30, 2025
CATX Perspective Therapeutics, Inc. Common Stock, $0.001 par value 4.2% $6.9M 2.84M Avidity Partners Management LP Dec 31, 2024
KZR Kezar Life Sciences, Inc. Common Stock, par value $0.001 per share 0% $0 0 Avidity Partners Management LP Sep 30, 2025

Schedules 13D/G Reported by Avidity Partners Management LP:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.